Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05439460Phase 4Completed
A Phase 4 trial of phenylephrine, epinephrine, vasopressin in pulmonary arterial hypertension (PAH), sponsored by Stanford University. Started Jan 2012; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05439460.